Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities

Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e330-e333
JournalCirculation
Volume132
Issue number22
DOIs
StatePublished - Dec 1 2015

Fingerprint

Performance-Enhancing Substances
Cardiovascular Abnormalities
Advisory Committees
Cardiology
Athletes
Pharmaceutical Preparations

Keywords

  • AHA Scientific Statements
  • athletes
  • cardiovascular abnormalities
  • drugs
  • performance-enhancing substances

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, & American College of Cardiology (2015). Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e330-e333. https://doi.org/10.1161/CIR.0000000000000247

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology. / on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Functional Genomics and Translational Biology; American College of Cardiology.

In: Circulation, Vol. 132, No. 22, 01.12.2015, p. e330-e333.

Research output: Contribution to journalArticle

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology & American College of Cardiology 2015, 'Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology', Circulation, vol. 132, no. 22, pp. e330-e333. https://doi.org/10.1161/CIR.0000000000000247
on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 1;132(22):e330-e333. https://doi.org/10.1161/CIR.0000000000000247
on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology ; Council on Cardiovascular Disease in the Young ; Council on Cardiovascular and Stroke Nursing ; Council on Functional Genomics and Translational Biology ; American College of Cardiology. / Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology. In: Circulation. 2015 ; Vol. 132, No. 22. pp. e330-e333.
@article{1927bc0075244bf2af756aa1b6fc1168,
title = "Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology",
keywords = "AHA Scientific Statements, athletes, cardiovascular abnormalities, drugs, performance-enhancing substances",
author = "{on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology} and {Council on Cardiovascular Disease in the Young} and {Council on Cardiovascular and Stroke Nursing} and {Council on Functional Genomics and Translational Biology} and {American College of Cardiology} and Estes, {N. A Mark} and Kovacs, {Richard J.} and Baggish, {Aaron L.} and Myerburg, {Robert J}",
year = "2015",
month = "12",
day = "1",
doi = "10.1161/CIR.0000000000000247",
language = "English (US)",
volume = "132",
pages = "e330--e333",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "22",

}

TY - JOUR

T1 - Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities

T2 - Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology

AU - on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

AU - Council on Cardiovascular Disease in the Young

AU - Council on Cardiovascular and Stroke Nursing

AU - Council on Functional Genomics and Translational Biology

AU - American College of Cardiology

AU - Estes, N. A Mark

AU - Kovacs, Richard J.

AU - Baggish, Aaron L.

AU - Myerburg, Robert J

PY - 2015/12/1

Y1 - 2015/12/1

KW - AHA Scientific Statements

KW - athletes

KW - cardiovascular abnormalities

KW - drugs

KW - performance-enhancing substances

UR - http://www.scopus.com/inward/record.url?scp=84949322934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949322934&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000247

DO - 10.1161/CIR.0000000000000247

M3 - Article

VL - 132

SP - e330-e333

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 22

ER -